0 results for 'Merck'
What Prompted a Leading E-Discovery Lawyer to Swap Sides of the 'V'
E-discovery expert Benjamin Barnett moved from Dechert to plaintiffs firm Seeger Weiss at the turn of the year.Plaintiff Lacks Standing to Show Bottles She Purchased Had Harmful Substances
Dechert Loses 2 Litigation Partners Who Held Leadership Roles
Former SDNY U.S. attorney David Kelley, former co-leader of the firm's white-collar practice, moved to O'Melveny & Myers. Benjamin Barnett, chair of the firm's technology committee, joined plaintiffs firm Seeger Weiss.Merck Faces $300M Breach-of-Contract Suit Over Manufacturing Agreement in India
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be the first to know about new suits in your region, practice area or client sector.Taking the Temperature of Litigation Leaders in 2023
Here's one last visit with the 16 leaders of Big Law litigation practices and elite boutiques we queried this year as part of our Litigation Leaders Q&A series.View more book results for the query "Merck"
Education Company's Legal Ops Overhaul Wins Acclaim, Saves Money
Despite budget constraints, Adtalem Global, the largest health care educator in the country, found myriad ways to boost the efficiency of its legal and compliance team.Merck Hit With Antitrust Suit Over Settlement for 2 Best-Selling Cholesterol Treatments
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."Juror Attitudes Toward Pharmaceutical Companies
In February 2023, the DOAR Research Center sought to shed light on changing attitudes toward the pharmaceutical industry by conducting a survey, which questioned respondents on their opinions of the pharmaceutical industry and their COVID-19 experiences. This article highlights the results of the survey.Third-party purchaser adequately pled antitrust injury against pharmaceutical company by alleging that it used loyalty conditions and bundled pricing to dissuade competition for one of its vaccines and thereby kept the price of that vaccine artificially inflated. Defendant's motion to dismiss denied in part and granted in part.
Communications Between Firm, Patent Counsel Are Subject to Attorney-Client Privilege
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now